Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

One Face, Three Solutions: Structural Convergence in PD-L1 Inhibition across Antibodies, Macrocycles, and Small Molecules.

Journal of medicinal chemistry·2026
Same author

The functional neuroanatomy of event-based and time-based prospective memory, and its improvement.

Communications biology·2026
Same author

The Binding of 3-O-Methylfluorescein Phosphate to the Catalytic Domain of the Human CDC25B Phosphatase: A Structural Investigation.

Chembiochem : a European journal of chemical biology·2026
Same author

Statistics and Ontology of Published Small Molecule Ring Systems.

Molecular informatics·2026
Same author

Crystallographic characterisation and development of bi-substrate inhibitors of coronavirus nsp14 methyltransferase.

RSC medicinal chemistry·2026
Same author

The essential co-chaperone Sgt1 regulates client dwell time in the Hsp90 chaperone cycle.

Molecular cell·2025

Related Experiment Video

Updated: Jul 3, 2026

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

NMR screening for lead compounds using tryptophan-mutated proteins.

Ulli Rothweiler1, Anna Czarna, Lutz Weber

  • 1Max Planck Institute for Biochemistry, D-82152 Martinsried, Germany.

Journal of Medicinal Chemistry
|August 6, 2008
PubMed
Summary

We developed a rapid NMR drug screening method using tryptophan. This technique efficiently characterizes ligand-protein interactions and binding affinities, improving upon traditional NMR methods.

More Related Videos

Chemical Modification of the Tryptophan Residue in a Recombinant Ca2+-ATPase N-domain for Studying Tryptophan-ANS FRET
12:07

Chemical Modification of the Tryptophan Residue in a Recombinant Ca2+-ATPase N-domain for Studying Tryptophan-ANS FRET

Published on: October 9, 2021

PCR Mutagenesis, Cloning, Expression, Fast Protein Purification Protocols and Crystallization of the Wild Type and Mutant Forms of Tryptophan Synthase
09:31

PCR Mutagenesis, Cloning, Expression, Fast Protein Purification Protocols and Crystallization of the Wild Type and Mutant Forms of Tryptophan Synthase

Published on: September 26, 2020

Related Experiment Videos

Last Updated: Jul 3, 2026

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

Chemical Modification of the Tryptophan Residue in a Recombinant Ca2+-ATPase N-domain for Studying Tryptophan-ANS FRET
12:07

Chemical Modification of the Tryptophan Residue in a Recombinant Ca2+-ATPase N-domain for Studying Tryptophan-ANS FRET

Published on: October 9, 2021

PCR Mutagenesis, Cloning, Expression, Fast Protein Purification Protocols and Crystallization of the Wild Type and Mutant Forms of Tryptophan Synthase
09:31

PCR Mutagenesis, Cloning, Expression, Fast Protein Purification Protocols and Crystallization of the Wild Type and Mutant Forms of Tryptophan Synthase

Published on: September 26, 2020

Area of Science:

  • Biochemistry
  • Structural Biology
  • Drug Discovery

Background:

  • Nuclear Magnetic Resonance (NMR) based drug screening is reliable but resource-intensive.
  • Traditional NMR requires significant protein quantities and long experiment times.
  • Efficient methods are needed to characterize ligand-protein binding.

Purpose of the Study:

  • To introduce a rapid NMR screening method using tryptophan.
  • To enable efficient characterization of ligand-protein and protein-protein interactions.
  • To quantify binding affinities (KDs) and binding fractions.

Main Methods:

  • Incorporation of tryptophan into target proteins.
  • Monitoring a 1D proton NMR signal of the tryptophan side chain.
  • Application to Mdm2-p53 and CDK2 inhibitor studies.

Main Results:

  • Demonstrated rapid screening via tryptophan NMR signals.
  • Successfully quantified binding affinities (KDs).
  • Characterized antagonist-protein and antagonist-protein-protein interactions.
  • Illustrated utility with Mdm2-p53 and CDK2 systems.

Conclusions:

  • Tryptophan-based NMR offers a faster, more efficient drug screening approach.
  • The method provides quantitative insights into molecular interactions.
  • This technique enhances the practicality of NMR for drug discovery.